Shenzhen - Delayed Quote CNY

Aier Eye Hospital Group Co., Ltd. (300015.SZ)

11.96 -0.12 (-0.99%)
At close: 3:04 PM GMT+8
Loading Chart for 300015.SZ
DELL
  • Previous Close 12.08
  • Open 12.36
  • Bid 11.96 x --
  • Ask 11.97 x --
  • Day's Range 11.81 - 12.08
  • 52 Week Range 11.80 - 23.27
  • Volume 60,232,514
  • Avg. Volume 77,381,646
  • Market Cap (intraday) 111.568B
  • Beta (5Y Monthly) 0.47
  • PE Ratio (TTM) 32.32
  • EPS (TTM) 0.37
  • Earnings Date Apr 26, 2024
  • Forward Dividend & Yield 0.10 (0.84%)
  • Ex-Dividend Date Jun 8, 2023
  • 1y Target Est 24.17

Aier Eye Hospital Group Co., Ltd. operates eye care hospitals and institutions. The company offers medical services in the areas of fundus diseases, optometry, refractive correction, glaucoma, corneal diseases, and cataract. It also provides training course for cataract prevention and treatment. The company operates ophthalmic hospitals in mainland China, Europe, the United States, Hong Kong, and Southeast Asia. The company was founded in 2007 and is headquartered in Changsha, China.

www.aierchina.com

32,326

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 300015.SZ

Performance Overview: 300015.SZ

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

300015.SZ
24.40%
SSE Composite Index
2.35%

1-Year Return

300015.SZ
44.76%
SSE Composite Index
7.77%

3-Year Return

300015.SZ
62.53%
SSE Composite Index
12.36%

5-Year Return

300015.SZ
32.07%
SSE Composite Index
4.81%

Compare To: 300015.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 300015.SZ

Valuation Measures

Annual
As of 4/24/2024
  • Market Cap

    111.57B

  • Enterprise Value

    108.55B

  • Trailing P/E

    32.68

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.70

  • Price/Book (mrq)

    5.96

  • Enterprise Value/Revenue

    5.68

  • Enterprise Value/EBITDA

    23.58

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    17.53%

  • Return on Assets (ttm)

    10.46%

  • Return on Equity (ttm)

    19.67%

  • Revenue (ttm)

    19.11B

  • Net Income Avi to Common (ttm)

    3.35B

  • Diluted EPS (ttm)

    0.37

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.61B

  • Total Debt/Equity (mrq)

    23.17%

  • Levered Free Cash Flow (ttm)

    2.94B

Research Analysis: 300015.SZ

Analyst Price Targets

18.70
24.17 Average
11.96 Current
31.87 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: 300015.SZ

People Also Watch